Abstract Details

Title Headache Disorders in Mexican Medical Students Registry: A Cross-sectional Study

Topic Headache

Presentation(s) P11 - Poster Session 11 (5:30 PM-6:30 PM)

Poster/Presentation
Number 12-009

Objective This study aims to assess: 1) the prevalence of primary headaches (PH) among medical students in Mexico; (2) to describe risk factors for Tensional Type Headache (TTH) and Migraine Headache (MH).

Background Headache is worldwide frequent, with an adult prevalence of 52%. There is a lack of data about headaches in the young population in Latin America. Occupational factors and emotional stress may play a role in the pathogenesis of headache, and this may explain a greater prevalence among medical students compared to general population.

Design/Methods An online survey was conducted among undergraduate medical students in San Luis Potosí, Mexico, from September 29^th, 2023 to October 09^th, 2023. For data collection, a semi-structured questionnaire was used, and a third independent blinded neurologist made diagnoses based on ICHD-3 criteria. The data was analyzed using IBM-SPSS V.25 for Mac.

Results 336 cases were analyzed, 138 (41.1%) male and 198 (58.9%) female, with 20.79 years old on average (SD 2.518). 247 (76.5%) individuals referred any type of headache, 42.8% out of those positive for TTH, 17.1% for MH, 8.6% for both MH/TTH and 31.5% did not fulfill criteria for MH nor for TTH. Medication overuse (MO) was found in 49%. MH was more prevalent in Female VS Male (30.4% VS 18%; P=0.31), TTH was more frequent in smokers VS non-smokers (64% vs 48.5%; P 0.46). Pain intensity was higher in MH VS non-MH (6.15 VS 5.16, T-student test, P=0.000), and MO was also more prevalent in patients with MH (64.2% vs 43.7%, P=0.004).

Conclusions In this first Mexican study of headache in medical students, it is confirmed that PH are more prevalent than in general population. These findings offer an important reference to promote screening and interventions to improve quality of life in our future healthcare professionals.

Authors/Disclosures
Denisse G. Martinez Roque, Jr. (Universidad Autonoma de San Luis Potosí) PRESENTER	Miss Martinez Roque has nothing to disclose.
Rodolfo M. Roman Guzman, Sr., MD (Hospital Central Dr. Ignacio Morones Prieto)	Dr. Roman Guzman has nothing to disclose.
Arturo G. Lara, MD (Hospital Central Dr. Ignacio Morones Prieto Departamento de Neurología)	Dr. Lara has nothing to disclose.
Melissa H. Vega, MD (Universidad Autónoma de San Luis Potosí)	Dr. Vega has nothing to disclose.
Francisco J. Rubio Chan, Sr.	Mr. Rubio Chan has nothing to disclose.
Guadalupe Y. Rojas Torres, Jr.	No disclosure on file
Ildefonso Rodriguez-Leyva, MD, PhD, FAAN (Facultad de Medicina, Universidad Autonoma de San Luis Potosi)	Dr. Rodriguez-Leyva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Dr. Rodriguez-Leyva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Laboratorios Columbia.

��ɫ��

��ɫ��